retatrutide 2.5 mg UK: New Triple-Agonist Weight Loss Injection Explained Retatrutide 5mg - MEDICA DEPOT
Description
2022, doi: 10.3390/cancers14092072
koevet Recently Joined No Source Discussion #16 Yes, it did and quite significantly
The medication addresses GLP-1 receptor activation
Wu N, Bredin SSD, Guan Y et al (2019) Cardiovascular health benefits of exercise training in persons living with type 1 diabetes: a systematic review and meta-analysis
Meanwhile, Mounjaro, Zepbound and the generic tirzepatide elevate both GLP-1 and a second anti-diabetes/anti-obesity hormone called GIP
If you want a practical look at how patients manage these effects day to day, tirzepatide side effects and management are a useful place to start
